Teva Pharmaceuticals USA, and other related companies (collectively, “Teva”), developed and obtained a patent for Copaxone, a drug used in the treatment of multiple sclerosis. See Teva Pharmaceuticals USA Inc. et al., v. Sandoz Inc., 876 F. Supp. 2d...